Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Vir Biotechnology, Inc.
Business Segments
Products & Services
Upfront payments
Upfront payments
Vir Biotechnology, Inc.
·
Products & Services
·
1 segment
Breakdown
Segments
License and collaboration revenue
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q2 '26
License and collaboration revenue
$239.3M
Total
$239.3M
